Cargando…
Longitudinal Characterization of the Gut Microbiota in the Diabetic ZDSD Rat Model and Therapeutic Potential of Oligofructose
The complex development of type 2 diabetes (T2D) creates challenges for studying the progression and treatment of the disease in animal models. A newly developed rat model of diabetes, the Zucker Diabetic Sprague Dawley (ZDSD) rat, closely parallels the progression of T2D in humans. Here, we examine...
Autores principales: | Weninger, Savanna N., Ding, Angela, Browne, Elizabeth N., Frost, Morgan L., Schiro, Gabriele, Laubitz, Daniel, Duca, Frank A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220957/ https://www.ncbi.nlm.nih.gov/pubmed/37233701 http://dx.doi.org/10.3390/metabo13050660 |
Ejemplares similares
-
Differential effects of plant-based flours on metabolic homeostasis and the gut microbiota in high-fat fed rats
por: Martinez, Taylor M., et al.
Publicado: (2023) -
Oligofructose improves small intestinal lipid-sensing mechanisms via alterations to the small intestinal microbiota
por: Weninger, Savanna N., et al.
Publicado: (2023) -
Role of the gut–brain axis in energy and glucose metabolism
por: Wachsmuth, Hallie R., et al.
Publicado: (2022) -
Zucker Diabetic‐Sprague Dawley (ZDSD) rat: Type 2 diabetes translational research model
por: Wang, Andrea N., et al.
Publicado: (2022) -
Combination of Oligofructose and Metformin Alters the Gut Microbiota and Improves Metabolic Profiles, Contributing to the Potentiated Therapeutic Effects on Diet-Induced Obese Animals
por: Li, Qingzhong, et al.
Publicado: (2020)